Survival Prediction on TCGA Overall
0.742C-indexMUST
Evaluation results
| Method | Links | ||
|---|---|---|---|
| MUSTPathology modality (P)=Observed, Genomic modality (G)=Observed2026.03 | 0.742 | — | |
| MUSTPathological Modality (P)=Yes, Genomic Modality (G)=Yes, Requires identical modalities for training and inference=false2026.03 | 0.742 | — | |
| MUSTPathology modality (P)=Missing, Genomic modality (G)=Observed2026.03 | 0.739 | — | |
| CMTAPathological Modality (P)=Yes, Genomic Modality (G)=Yes, Requires identical modalities for training and inference=true2026.03 | 0.724 | — | |
| LD-CVAEPathology modality (P)=Observed, Genomic modality (G)=Observed2026.03 | 0.723 | — | |
| SMILPathology modality (P)=Observed, Genomic modality (G)=Observed2026.03 | 0.719 | — | |
| MUSTPathology modality (P)=Observed, Genomic modality (G)=Missing2026.03 | 0.716 | — | |
| SurvPathPathological Modality (P)=Yes, Genomic Modality (G)=Yes, Requires identical modalities for training and inference=true2026.03 | 0.713 | — | |
| M3CarePathology modality (P)=Observed, Genomic modality (G)=Observed2026.03 | 0.71 | — | |
| ShaSpecPathology modality (P)=Observed, Genomic modality (G)=Observed2026.03 | 0.709 | — | |
| PathMoGSample Size (N)=5650, Evaluation Protocol=sample-size-weighted average2026.04 | 0.708 | 75.1 | |
| ABMILPathological Modality (P)=Yes, Genomic Modality (G)=No, Requires identical modalities for training and inference=true2026.03 | 0.7 | — | |
| SNNPathological Modality (P)=No, Genomic Modality (G)=Yes, Requires identical modalities for training and inference=true2026.03 | 0.7 | — | |
| LD-CVAEPathology modality (P)=Observed, Genomic modality (G)=Missing2026.03 | 0.697 | — | |
| TransMILPathological Modality (P)=Yes, Genomic Modality (G)=No, Requires identical modalities for training and inference=true2026.03 | 0.696 | — | |
| M3CarePathology modality (P)=Observed, Genomic modality (G)=Missing2026.03 | 0.689 | — | |
| MLPPathological Modality (P)=No, Genomic Modality (G)=Yes, Requires identical modalities for training and inference=true2026.03 | 0.689 | — | |
| SMILPathology modality (P)=Missing, Genomic modality (G)=Observed2026.03 | 0.687 | — | |
| M3CarePathology modality (P)=Missing, Genomic modality (G)=Observed2026.03 | 0.683 | — | |
| ShaSpecPathology modality (P)=Observed, Genomic modality (G)=Missing2026.03 | 0.676 | — | |
| ShaSpecPathology modality (P)=Missing, Genomic modality (G)=Observed2026.03 | 0.676 | — | |
| PCLSample Size (N)=5650, Evaluation Protocol=sample-size-weighted average2026.04 | 0.675 | 68.9 | |
| FGCNSample Size (N)=5650, Evaluation Protocol=sample-size-weighted average2026.04 | 0.664 | 66.2 | |
| CAMRSample Size (N)=5650, Evaluation Protocol=sample-size-weighted average2026.04 | 0.651 | 68.6 | |
| PathGSample Size (N)=5650, Evaluation Protocol=sample-size-weighted average2026.04 | 0.625 | 67.4 | |
| SMILPathology modality (P)=Observed, Genomic modality (G)=Missing2026.03 | 0.624 | — | |
| RSFSample Size (N)=5650, Evaluation Protocol=sample-size-weighted average2026.04 | 0.62 | 61.6 | |
| CoxSample Size (N)=5650, Evaluation Protocol=sample-size-weighted average2026.04 | 0.618 | 61.5 | |
| HFBSample Size (N)=5650, Evaluation Protocol=sample-size-weighted average2026.04 | 0.612 | 57.6 | |
| GraphSSample Size (N)=5650, Evaluation Protocol=sample-size-weighted average2026.04 | 0.601 | 65.3 |